The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).
 
Deepa Bhojwani
Travel, Accommodations, Expenses - Amgen
 
Richard Sposto
No Relationships to Disclose
 
Nirali Shah
No Relationships to Disclose
 
Vilmarie Rodriguez
Other Relationship - Bristol-Myers Squibb
 
Maureen Megan O'Brien
Consulting or Advisory Role - Amgen
Research Funding - Amgen (Inst); Celgene (Inst); Epizyme (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene
 
Jennifer Lynn McNeer
No Relationships to Disclose
 
Mignon L. Loh
No Relationships to Disclose
 
Susan R. Rheingold
Employment - Axovant Sciences (I)
Stock and Other Ownership Interests - Axovant Sciences (I); Endo Pharmaceuticals (I)